Resumo

LEON-GOMEZ, Juanita. Liver implications during the COVID-19 Pandemic. Rev Col Gastroenterol [online]. 2020, vol.35, suppl.1, pp.30-36. ISSN 0120-9957.  https://doi.org/10.22516/25007440.535.

The infection generated by the novel coronavirus SARS-CoV-2, named Coronavirus Disease 2019 (COVID-19) emerged late December of 2019 in China. It is currently categorized as a pandemic by the World Health Organization. Studies have focused on cardiac, pulmonary, and renal effects of this infection, but liver test abnormalities have also been documented. This alteration may be a consequence of viral hepatitis, pharmacological toxicity, inflammation, or shock. It is also considered a marker of prognosis and severity of the disease. The impact of SARS-CoV-2 infection in patients with pre-existing liver disease or liver transplant recipients is unclear, and different hypotheses exist regarding the higher or lower risk of severe disease and decompensation of the underlying disease.

Palavras-chave : SARS-CoV; SARS-CoV-2; MERS-CoV; liver; liver transplant; cirrhosis; immunosuppression.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )